284 related articles for article (PubMed ID: 17259872)
21. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
23. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
24. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
Hammitt LL; Bulkow L; Hennessy TW; Zanis C; Snowball M; Williams JL; Bell BP; McMahon BJ
J Infect Dis; 2008 Dec; 198(12):1776-82. PubMed ID: 18976095
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.
Van Der Wielen M; Vertruyen A; Froesner G; Ibáñez R; Hunt M; Herzog C; Van Damme P
Pediatr Infect Dis J; 2007 Aug; 26(8):705-10. PubMed ID: 17848882
[TBL] [Abstract][Full Text] [Related]
26. [The immunological effects of three doses of a live attenuated hepatitis A vaccine (H2 strain) in 8 years].
Liu HF; Zhang XJ; Zhang JL; Hao ZY; Zhang ZY; Ma JC; Chen JC; Chu J; Wang XY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):180-1. PubMed ID: 20104771
[TBL] [Abstract][Full Text] [Related]
27. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
28. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of hepatitis A-inactivated vaccine administered to seronegative infants, and serological follow-up 12 months after second dose.
De Silvestri A; Zara F; Terulla V; Brerra R; Zucca S; Belloni C
Acta Paediatr; 2006 Dec; 95(12):1582-5. PubMed ID: 17129966
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
Wang X; Meng Z; Li R
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
[TBL] [Abstract][Full Text] [Related]
31. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
Vidor E
J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
[TBL] [Abstract][Full Text] [Related]
33. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of hepatitis A vaccine in children with celiac disease.
Sari S; Dalgic B; Basturk B; Gonen S; Soylemezoglu O
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):532-5. PubMed ID: 21587080
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
36. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
[TBL] [Abstract][Full Text] [Related]
37. [Studies on vaccination schedule of inactivated hepatitis A vaccine].
Hu Y; Tan S; Jin W
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):618-20. PubMed ID: 11798830
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
[TBL] [Abstract][Full Text] [Related]
40. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
